These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Telomerase inhibition as cancer therapy. Saretzki G Cancer Lett; 2003 May; 194(2):209-19. PubMed ID: 12757979 [TBL] [Abstract][Full Text] [Related]
3. Telomerase: a target for cancer therapeutics. Shay JW; Wright WE Cancer Cell; 2002 Oct; 2(4):257-65. PubMed ID: 12398889 [TBL] [Abstract][Full Text] [Related]
4. Changing Direction: From Therapeutic Telomerase Inhibition to Activation? Bär C; Thum T Circ Res; 2017 Apr; 120(9):1393-1395. PubMed ID: 28450362 [No Abstract] [Full Text] [Related]
5. Telomeres and senescence: ending the debate. de Lange T Science; 1998 Jan; 279(5349):334-5. PubMed ID: 9454329 [No Abstract] [Full Text] [Related]
6. Telomeres and telomerases in cancer. Novak KD MedGenMed; 2003 Jan; 5(1):21. PubMed ID: 12827082 [No Abstract] [Full Text] [Related]
7. Telomerase as an emerging target to fight cancer--opportunities and challenges for nanomedicine. Philippi C; Loretz B; Schaefer UF; Lehr CM J Control Release; 2010 Sep; 146(2):228-40. PubMed ID: 20381558 [TBL] [Abstract][Full Text] [Related]
8. Telomerase inhibitors: a new option for chemotherapy. Chen Z; Corey DR Adv Cancer Res; 2003; 87():31-58. PubMed ID: 12641273 [TBL] [Abstract][Full Text] [Related]
11. Telomere biology of pediatric cancer. Tabori U; Dome JS Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490 [TBL] [Abstract][Full Text] [Related]
12. The significance of telomerase activation and cellular immortalization in human cancer. Newbold RF Mutagenesis; 2002 Nov; 17(6):539-50. PubMed ID: 12435851 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease. Tárkányi I; Aradi J Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408 [TBL] [Abstract][Full Text] [Related]
15. Telomerase as a target for cancer therapy. Parkinson KE Curr Opin Investig Drugs; 2005 Jun; 6(6):605-10. PubMed ID: 15988912 [TBL] [Abstract][Full Text] [Related]
16. Oligonucleotide inhibitors of telomerase: prospects for anticancer therapy and diagnostics. Zvereva MI; Zatsepin TS; Azhibek DM; Shubernetskaya OS; Shpanchenko OV; Dontsova OA Biochemistry (Mosc); 2015 Mar; 80(3):251-9. PubMed ID: 25761680 [TBL] [Abstract][Full Text] [Related]
17. Stilbene Compounds Inhibit Tumor Growth by the Induction of Cellular Senescence and the Inhibition of Telomerase Activity. Lee YH; Chen YY; Yeh YL; Wang YJ; Chen RJ Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159515 [No Abstract] [Full Text] [Related]
18. Anticancer therapy targeting telomeres and telomerase : current status. Parkinson EK; Minty F BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621 [TBL] [Abstract][Full Text] [Related]
19. Drug insight: Cancer cell immortality-telomerase as a target for novel cancer gene therapies. Keith WN; Bilsland A; Hardie M; Evans TR Nat Clin Pract Oncol; 2004 Dec; 1(2):88-96. PubMed ID: 16264826 [TBL] [Abstract][Full Text] [Related]
20. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity. Rankin AM; Faller DV; Spanjaard RA Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]